Recent Articles

August 29, 2014 8:30 am
Steve Scribner, Principal Consultant – Life Sciences, EMC Information Intelligence Group
Getting a new drug from the laboratory to the pharmacy takes years of testing, applications and information sharing. One way to shorten the drug development life cycle is to optimize content management. Read more...          
August 28, 2014 9:30 am
Maxim Mikheev, M.D., Ph.D., Co-Founder and Chief Technical Officer at BioDatomics
As technological improvements have changed the way we study the genome, the amount of data associated with a single DNA sample has increased exponentially. Surprisingly, throughout this evolution the hardware and software infrastructure supporting bioanalytics has barely changed. Read more...
August 27, 2014 9:58 am
Seth Lederman, M.D., CEO, Tonix Pharmaceuticals
Drugs can be discovered and developed in two very different ways: at an evolutionary pace and at a revolutionary pace. The “first revolution” in biological psychiatry took place in the 1950s, and now, in the 21st century, a “second revolution” of drug development and discovery is taking place, driven by repurposing.
August 26, 2014 11:31 am
Cynthia Fox, Science Editor
An experimental drug saved the lives of 16 of 16 monkeys with the Marburg virus, a killer near-indistinguishable from Ebola, just as symptoms broke out, said a new study. Read more...                   
August 25, 2014 9:49 am
Cynthia Fox, Science Editor
The birth control pill significantly affects ovarian reserve— or the number of immature eggs in a woman’s ovaries— which can be a predictor of future fertility, according to a team in Denmark. Read more...             
August 22, 2014 10:34 am
By Louise Rozik, Editor
Neglected by the pharmaceutical industry before the Orphan Drug Act of 1983, rare diseases are now front and center in pharma R&D, with approximately one-third of all new medicines approved by the FDA in the past 5 years were developed for the treatment of diseases that affect fewer than 200,000 Americans. Read more...
August 21, 2014 3:02 pm
Cynthia Fox, Science Writer
As, all around them, everyone from Derek Jeter to the Kennedy family was dousing themselves in ice water for the ALS “Ice Bucket Challenge,” Harvard researchers announced last week they may have found an ALS therapy. Read more...      
August 20, 2014 11:10 am
Chris Plaford, CFA, Chief Executive Officer, Claravant Analytics LLC
According to industry estimates, the majority of drugs in development will never make it to FDA approval. While a lack of efficacy is often a key factor, many clinical programs are derailed due to avoidable setbacks that can cause delays and significantly increase costs. Read more...
August 19, 2014 11:23 am
Sharon Benzeno, PhD, MBA, Senior Director, Business Development Bioinformatics, Elsevier
Big data is one of the hottest topics in R&D as its potential to accelerate successful drug development becomes more widely recognized. Part 2 of this two-part article analyses the new data-driven decision-making approaches make a difference to life science R&D. Read more...
August 18, 2014 3:14 pm
Cynthia Fox, Science Editor
A scientist has found that a compound, LY-411575, can restore 20% of hearing in deaf mice, or ten decibels. Since electroacoustic hearing aids, at best, improve hearing by five decibels, there is a “good chance” the work will lead to help for deafened patients.
Subscribe to Drug Discovery & Development